AN2 Therapeutics, Inc. (ANTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$35.17M | +31.5% |
| 2024 | -$51.32M | +20.7% |
| 2023 | -$64.73M | -58.1% |
| 2022 | -$40.96M | -90.1% |
| 2021 | -$21.54M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$35.17M | +31.5% |
| 2024 | -$51.32M | +20.7% |
| 2023 | -$64.73M | -58.1% |
| 2022 | -$40.96M | -90.1% |
| 2021 | -$21.54M | — |